IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

Equity Capital Markets

<div><p><a href="https://www.smartkarma.com/entities/blue-moon-group-holdings" target="_blank" data-smartkarma-citation="entities:29179:1" rel="noopener">Blue Moon Group Holdings (6993 HK)</a> is a leading consumer household care company in China.  Blue Moon will commence trading on Wednesday, 16 December. Blue Moon priced its IPO at HK$13.16 and <a href="http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1063245/ipo-news" target="_blank" rel="noopener">opened 14% higher</a> at HK$15.00 in the grey market and last stood at HK$14.90.</p></div><div><p>In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-initiation-laundry-list" target="_blank" data-smartkarma-citation="insights:41086" rel="noopener">Blue Moon IPO Initiation: Laundry List</a>, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-doing-the-wash" target="_blank" data-smartkarma-citation="insights:45481" rel="noopener">Blue Moon IPO: Doing the Wash</a> we noted that the 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-valuation-insights" target="_blank" data-smartkarma-citation="insights:46033" rel="noopener">Blue Moon IPO: Valuation Insights</a>, we noted that the IPO price range is attractive.</p></div><div><div><div class="content-highlight"><p>Our base-case DCF derived price target of HK$15.21 per share. As DCF-based target prices are subject to a wide range of variability, we present a sensitivity table to help investors gauge where target prices could head. Our DCF sensitivity analysis shows that the IPO price continues to provide good upside potential. </p></div></div></div>

Blue Moon Group Holdings (6993 HK) is a leading consumer household care company in China.  Blue Moon will commence trading on Wednesday, 16 December. Blue Moon priced its IPO at HK$13.16 and opened 14% higher at HK$15.00 in the grey market and last stood at HK$14.90.In Blue Moon IPO Initiation: Laundry List, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). In Blue Moon IPO: Doing the Wash we noted that the 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. In Blue Moon IPO: Valuation Insights, we noted that the IPO price range is attractive.Our base-case DCF derived price target of HK$15.21 per share. As DCF-based target prices are subject to a wide range of variability, we present a sensitivity table to help investors gauge where target prices could head. Our DCF sensitivity analysis shows that the IPO price continues to provide good upside potential. 

<div>
<p><a href="https://www.smartkarma.com/entities/guangzhou-blue-moon-industry-co-ltd" target="_blank" data-smartkarma-citation="entities:29179:1" rel="noopener">Blue Moon Group Holdings (BMG HK)</a> is a leading consumer household care company in China. At the proposed IPO price range of HK$10.20-13.16 per share, Blue Moon will have a market cap of HK$58,621-75,632 million ($7.6-9.8 billion). At the mid-point of the IPO price range, the total net proceeds are HK$8,492 million ($1.1 billion). </p>
<p>Six cornerstone investors will subscribe for HK$1,821 million ($235 million) of the offer shares (20.87% of the offer shares at the mid-point of the price range). The cornerstone investors are BOCHK Asset Management, <a href="https://www.smartkarma.com/entities/shanghai-dazhong-public-utilities-a" target="_blank" data-smartkarma-citation="entities:7847:1" rel="noopener">Shanghai Dazhong Public Utilities - A (600635 CH)</a>,  Fullerton, Changjia Group, Greater Bay Area Fund and Veritas Asset Management.</p>
</div><div><div class="content-highlight"><p>In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-initiation-laundry-list" target="_blank" data-smartkarma-citation="insights:41086" rel="noopener">Blue Moon IPO Initiation: Laundry List</a>, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-doing-the-wash" target="_blank" data-smartkarma-citation="insights:45481" rel="noopener">Blue Moon IPO: Doing the Wash</a> we noted that the 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. Overall, we would participate in the IPO due to an attractive IPO price range.</p></div></div>


Blue Moon Group Holdings (BMG HK) is a leading consumer household care company in China. At the proposed IPO price range of HK$10.20-13.16 per share, Blue Moon will have a market cap of HK$58,621-75,632 million ($7.6-9.8 billion). At the mid-point of the IPO price range, the total net proceeds are HK$8,492 million ($1.1 billion). 
Six cornerstone investors will subscribe for HK$1,821 million ($235 million) of the offer shares (20.87% of the offer shares at the mid-point of the price range). The cornerstone investors are BOCHK Asset Management, Shanghai Dazhong Public Utilities - A (600635 CH),  Fullerton, Changjia Group, Greater Bay Area Fund and Veritas Asset Management.
In Blue Moon IPO Initiation: Laundry List, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). In Blue Moon IPO: Doing the Wash we noted that the 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. Overall, we would participate in the IPO due to an attractive IPO price range.

<div><p><a href="https://www.smartkarma.com/entities/guangzhou-blue-moon-industry-co-ltd" target="_blank" data-smartkarma-citation="entities:29179:1" rel="noopener">Blue Moon Group Holdings (BMG HK)</a> is a leading consumer household care company in China. In 2019, Blue Moon ranked first in China’s liquid laundry detergent market, concentrated liquid laundry detergent market and liquid soap market as measured by retail sales value, with a market share of 24.4%, 27.9% and 17.4%, respectively, according to Frost &amp; Sullivan. Blue Moon aims to kick-off its $1 billion IPO as soon as this week and one of the underwriters (UBS) has valued Blue Moon at HK$78.0-93.6 billion, according to <a href="http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1059856/ipo-news" target="_blank" rel="noopener">press reports</a>.</p></div><div><div class="content-highlight"><p>In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-initiation-laundry-list" target="_blank" data-smartkarma-citation="insights:41086" rel="noopener">Blue Moon IPO Initiation: Laundry List</a>, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-doing-the-wash" target="_blank" data-smartkarma-citation="insights:45481" rel="noopener">Blue Moon IPO: Doing the Wash</a> we noted that the 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. Overall, based on valuation analysis, we think that the underwriters' valuation range can be justified.</p></div></div>

Blue Moon Group Holdings (BMG HK) is a leading consumer household care company in China. In 2019, Blue Moon ranked first in China’s liquid laundry detergent market, concentrated liquid laundry detergent market and liquid soap market as measured by retail sales value, with a market share of 24.4%, 27.9% and 17.4%, respectively, according to Frost &amp; Sullivan. Blue Moon aims to kick-off its $1 billion IPO as soon as this week and one of the underwriters (UBS) has valued Blue Moon at HK$78.0-93.6 billion, according to press reports.In Blue Moon IPO Initiation: Laundry List, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). In Blue Moon IPO: Doing the Wash we noted that the 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. Overall, based on valuation analysis, we think that the underwriters' valuation range can be justified.

<p><a href="https://www.smartkarma.com/entities/guangzhou-blue-moon-industry-co-ltd" target="_blank" data-smartkarma-citation="entities:29179:1" rel="noopener">Blue Moon Group Holdings (BMG HK)</a> is a leading consumer household care company in China. In 2019, Blue Moon ranked first in China’s liquid laundry detergent market, concentrated liquid laundry detergent market and liquid soap market as measured by retail sales value, with a market share of 24.4%, 27.9% and 17.4%, respectively, according to Frost &amp; Sullivan. Blue Moon has filed its PHIP and is pre-marketing for a Hong Kong IPO to raise $1 billion, according to press reports.</p><div class="content-highlight"><p>In <a href="https://www.smartkarma.com/insights/blue-moon-ipo-initiation-laundry-list" target="_blank" data-smartkarma-citation="insights:41086" rel="noopener">Blue Moon IPO Initiation: Laundry List</a>, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). The 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. With the impact of the COVID-19 outbreak gradually receding in China, Blue Moon has strong fundamentals to ride a recovery in demand for its core fabric care products. Overall, we continue to believe that Blue Moon’s fundamentals are attractive.</p></div>

Blue Moon Group Holdings (BMG HK) is a leading consumer household care company in China. In 2019, Blue Moon ranked first in China’s liquid laundry detergent market, concentrated liquid laundry detergent market and liquid soap market as measured by retail sales value, with a market share of 24.4%, 27.9% and 17.4%, respectively, according to Frost &amp; Sullivan. Blue Moon has filed its PHIP and is pre-marketing for a Hong Kong IPO to raise $1 billion, according to press reports.In Blue Moon IPO Initiation: Laundry List, we stated that on balance we think the positives (market-leading brand, strong margin progression, solid cash generation) outweigh the negatives (declining revenue growth and short-term COVID-19 impact). The 1H20 results disclosed in the PHIP show that the Blue Moon has creditably navigated the adverse revenue decline on its core business due to the COVID-19 outbreak by improving margin and cash generation. With the impact of the COVID-19 outbreak gradually receding in China, Blue Moon has strong fundamentals to ride a recovery in demand for its core fabric care products. Overall, we continue to believe that Blue Moon’s fundamentals are attractive.

Making sense of the Global Market, Euromonitor International Ltd.

Yu Mitsuhashi

Making sense of the Global Market

Euromonitor International Ltd.

We are a global market research company focused on industries, countries, economies and consumers worldwide. Our cross-country comparable research helps your organisation identify opportunities and develop growth strategies in countries and regions across the globe. With offices around the world, 1,200 analysts in 100 countries and market research on every key trend and driver, we give you powerful access to the real story behind consumer change.

Equity Bottom-Up

<p>Reckitt Benckiser Group (RB) is currently in “advanced” talks to buy Mead Johnson Nutrition Co for USD16.7 billion, in a deal that makes little market overlap sense on the surface but could hint at future strategic plans. Reckitt Benckiser’s existing brands currently centre on home care, consumer health and beauty and personal care, and have little to do with baby milk formula, dairy or even packaged food to a larger extent.</p><p>As such, Reckitt Benckiser is moving in the opposite direction of most other FMCG companies, by pursuing even further diversification rather than specialization on existing core brands and categories. The “modern era” for RB started with the acquisition of Boots OTC business in 2006, bringing brands such as Strepsils and Clearasil under RB’s umbrella. Since then, RB has been making a steady strategic push into Consumer Health through a number of M&amp;As.</p><p>If Mead Johnson’s acquisition goes through, it could become a catalyst for Reckitt Benckiser to spin off its home care brands, some of which it has owned for more than 100 years, and build a more "fit" oriented business focusing on potentially more lucrative consumer health and hygiene businesses.</p>

Reckitt Benckiser Group (RB) is currently in “advanced” talks to buy Mead Johnson Nutrition Co for USD16.7 billion, in a deal that makes little market overlap sense on the surface but could hint at future strategic plans. Reckitt Benckiser’s existing brands currently centre on home care, consumer health and beauty and personal care, and have little to do with baby milk formula, dairy or even packaged food to a larger extent.As such, Reckitt Benckiser is moving in the opposite direction of most other FMCG companies, by pursuing even further diversification rather than specialization on existing core brands and categories. The “modern era” for RB started with the acquisition of Boots OTC business in 2006, bringing brands such as Strepsils and Clearasil under RB’s umbrella. Since then, RB has been making a steady strategic push into Consumer Health through a number of M&amp;As.If Mead Johnson’s acquisition goes through, it could become a catalyst for Reckitt Benckiser to spin off its home care brands, some of which it has owned for more than 100 years, and build a more "fit" oriented business focusing on potentially more lucrative consumer health and hygiene businesses.

If Reckitt Benckiser Buys Mead Johnson Then Is a Home Care Spinoff Next?

United States

Colgate-Palmolive Company is a consumer products company that markets its products throughout the world.  The Company's products include toothpaste, toothbrushes, shampoos, deodorants, bar and liquid soaps, dishwashing liquid, and laundry products, as well as pet nutrition products for cats and dogs.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Colgate Palmolive Co (CL US)

Blue Moon IPO: Trading Debut

Blue Moon priced its IPO at HK$13.16 and opened 14% higher at HK$15.00 in the grey market. Our DCF sensitivity analysis shows that the IPO price...

Arun George

Blue Moon IPO: Valuation Insights

Blue Moon has launched its HK IPO to raise net proceeds of $1.1 billion, at the mid-point of the HK$10.20-13.16 price range. Overall, we think that...

Arun George

Blue Moon IPO: Valuation First Look

Blue Moon aims to kick-off its $1 billion IPO as soon as this week and one of the underwriters (UBS) has valued Blue Moon at HK$78.0-93.6 billion....

Arun George

Blue Moon IPO: Doing the Wash

Blue Moon is pre-marketing for an HK IPO to raise $1 billion. With the impact of the COVID-19 outbreak receding, Blue Moon has strong fundamentals...

Arun George

If Reckitt Benckiser Buys Mead Johnson Then Is a Home Care Spinoff Next?

Reckitt Benckiser Group (RB) is currently in “advanced” talks to buy Mead Johnson Nutrition Co for USD16.7 billion, in a deal that makes little...

Euromonitor International Ltd.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)